RAC 2.92% $1.94 race oncology ltd

Ann: Compelling Preclinical Breast Cancer Results, page-80

  1. 15,728 Posts.
    lightbulb Created with Sketch. 1793
    Cool. That is what I am thinking of.

    Todays ANN is enhancing Pillar 2: George Clinical Breast Cancer trial review.

    Question, when will it be announced? LOL
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.